These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37203195)

  • 1. Angiopep-2 modified dual drug-loaded liposomes with brain targeting functionality mitigate Alzheimer's disease-related symptoms in APP/PS-1 mice.
    Zhang X; Shi N; Chen M; Liu M; Ju R; Liu Y; Kong L; Yu Y; Li X
    J Drug Target; 2023 Jul; 31(6):634-645. PubMed ID: 37203195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ApoE-modified liposomes encapsulating resveratrol and salidroside alleviate manifestations of Alzheimer's disease in APP/PS-1 mice.
    Chen MH; Liu XZ; Qu XW; Guo RB; Zhang L; Kong L; Yu Y; Liu Y; Zang J; Li XY; Li XT
    Drug Dev Ind Pharm; 2023 Sep; 49(9):559-571. PubMed ID: 37649422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifunctional icariin and tanshinone IIA co-delivery liposomes with potential application for Alzheimer's disease.
    Wang J; Kong L; Guo RB; He SY; Liu XZ; Zhang L; Liu Y; Yu Y; Li XT; Cheng L
    Drug Deliv; 2022 Dec; 29(1):1648-1662. PubMed ID: 35616263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transferrin-Modified Osthole PEGylated Liposomes Travel the Blood-Brain Barrier and Mitigate Alzheimer's Disease-Related Pathology in APP/PS-1 Mice.
    Kong L; Li XT; Ni YN; Xiao HH; Yao YJ; Wang YY; Ju RJ; Li HY; Liu JJ; Fu M; Wu YT; Yang JX; Cheng L
    Int J Nanomedicine; 2020; 15():2841-2858. PubMed ID: 32425521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Borneol-Modified Schisandrin B Micelles Cross the Blood-Brain Barrier To Treat Alzheimer's Disease in Aged Mice.
    Li FR; Yu Y; Du YM; Kong L; Liu Y; Wang JH; Chen MH; Liu M; Zhang ZX; Li XT; Ju RJ
    ACS Chem Neurosci; 2024 Feb; 15(3):593-607. PubMed ID: 38214579
    [No Abstract]   [Full Text] [Related]  

  • 6. A Novel Delivery System of Cyclovirobuxine D for Brain Targeting: Angiopep-Conjugated Polysorbate 80-Coated Liposomes via Intranasal Administration.
    Wei H; Liu T; Jiang N; Zhou K; Yang K; Ning W; Yu Y
    J Biomed Nanotechnol; 2018 Jul; 14(7):1252-1262. PubMed ID: 29944099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multifunctional LUV liposomes decorated for BBB and amyloid targeting - B. In vivo brain targeting potential in wild-type and APP/PS1 mice.
    Papadia K; Giannou AD; Markoutsa E; Bigot C; Vanhoute G; Mourtas S; Van der Linded A; Stathopoulos GT; Antimisiaris SG
    Eur J Pharm Sci; 2017 May; 102():180-187. PubMed ID: 28285172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiopep-2-modified calcium arsenite-loaded liposomes for targeted and pH-responsive delivery for anti-glioma therapy.
    Xu H; Li C; Wei Y; Zheng H; Zheng H; Wang B; Piao JG; Li F
    Biochem Biophys Res Commun; 2021 Apr; 551():14-20. PubMed ID: 33714754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transferrin-modified liposome promotes α-mangostin to penetrate the blood-brain barrier.
    Chen ZL; Huang M; Wang XR; Fu J; Han M; Shen YQ; Xia Z; Gao JQ
    Nanomedicine; 2016 Feb; 12(2):421-30. PubMed ID: 26711963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glioma targeted delivery strategy of doxorubicin-loaded liposomes by dual-ligand modification.
    Han W; Yin G; Pu X; Chen X; Liao X; Huang Z
    J Biomater Sci Polym Ed; 2017 Oct; 28(15):1695-1712. PubMed ID: 28699828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Menthol-Modified Quercetin Liposomes with Brain-Targeting Function for the Treatment of Senescent Alzheimer's Disease.
    Liu WY; Yu Y; Zang J; Liu Y; Li FR; Zhang L; Guo RB; Kong L; Ma LY; Li XT
    ACS Chem Neurosci; 2024 Jun; 15(11):2283-2295. PubMed ID: 38780450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ApoE-2 Brain-Targeted Gene Therapy Through Transferrin and Penetratin Tagged Liposomal Nanoparticles.
    Dos Santos Rodrigues B; Kanekiyo T; Singh J
    Pharm Res; 2019 Sep; 36(11):161. PubMed ID: 31529284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide-22 and Cyclic RGD Functionalized Liposomes for Glioma Targeting Drug Delivery Overcoming BBB and BBTB.
    Chen C; Duan Z; Yuan Y; Li R; Pang L; Liang J; Xu X; Wang J
    ACS Appl Mater Interfaces; 2017 Feb; 9(7):5864-5873. PubMed ID: 28128553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nerve Growth Factor Gene Delivery across the Blood-Brain Barrier to Reduce Beta Amyloid Accumulation in AD Mice.
    Rodrigues BDS; Kanekiyo T; Singh J
    Mol Pharm; 2020 Jun; 17(6):2054-2063. PubMed ID: 32315185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multifunctional osthole liposomes and brain targeting functionality with potential applications in a mouse model of Alzheimer's disease.
    Ni YN; Kong L; Li XT; Xiao HH; Wu YT; Liang XC; Lin Y; Li WY; Deng Y; Li Y; Shi Y; Cheng L; Li HY; Ju RJ; Yang JX
    J Liposome Res; 2021 Sep; 31(3):267-278. PubMed ID: 32757676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of glucose-modified liposomes using polyethylene glycols with different chain lengths as the linkers for brain targeting.
    Xie F; Yao N; Qin Y; Zhang Q; Chen H; Yuan M; Tang J; Li X; Fan W; Zhang Q; Wu Y; Hai L; He Q
    Int J Nanomedicine; 2012; 7():163-75. PubMed ID: 22275832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a brain-targeted nano drug delivery system to enhance the treatment of neurodegenerative effects of resveratrol.
    Yu Y; Li S; Kong L; Du Y; Liu Y; Zang J; Guo R; Zhang L; Zhao Z; Ju R; Li X
    J Liposome Res; 2024 Sep; 34(3):435-451. PubMed ID: 38032385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sialic acid (SA)-modified selenium nanoparticles coated with a high blood-brain barrier permeability peptide-B6 peptide for potential use in Alzheimer's disease.
    Yin T; Yang L; Liu Y; Zhou X; Sun J; Liu J
    Acta Biomater; 2015 Oct; 25():172-83. PubMed ID: 26143603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimized liposomes with transactivator of transcription peptide and anti-apoptotic drugs to target hippocampal neurons and prevent tau-hyperphosphorylated neurodegeneration.
    Kuo YC; Chen CL; Rajesh R
    Acta Biomater; 2019 Mar; 87():207-222. PubMed ID: 30716553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advancements in liposomes targeting strategies to cross blood-brain barrier (BBB) for the treatment of Alzheimer's disease.
    Agrawal M; Ajazuddin ; Tripathi DK; Saraf S; Saraf S; Antimisiaris SG; Mourtas S; Hammarlund-Udenaes M; Alexander A
    J Control Release; 2017 Aug; 260():61-77. PubMed ID: 28549949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.